Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland
GlobeNewswire, Inc.
— The new pricing structure is made available as of February for 12,67 PLN per day at pharmacies throughout Poland AMSTERDAM, April 30, 2026 (GLOBE NEWSWIRE) -- VIVUS BV, a subsidiary of VIVUS LLC, a biopharmaceutical company committed to the...
Ojemda® approved in the European Union as the first targeted therapy in relapsed or refractory pediatric low-grade glioma regardless of BRAF alteration
GlobeNewswire, Inc.
New treatment option for rare, life-altering pediatric brain tumors Less than 10% of new medicine approvals over the past five years have focused on pediatric diseases; Ojemda® (tovorafenib) represents a rare achievement that reinforces the urgent...
Akari Therapeutics Secures Key European Patent For Its Novel RNA Splicing Modulator ADC Payload, Strengthening Global IP Estate For All Major Global Markets
GlobeNewswire, Inc.
TAMPA, Fla. and LONDON, May 12, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel RNA splicing modulator payloads, today announced the grant of...
Alvotech Files Annual Report with the SEC
GlobeNewswire, Inc.
REYKJAVIK, Iceland, March 30, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO) (the “Company”) has filed its Annual Report 2025 on Form 20-F for the financial year 2025 with the U.S. Securities and Exchange Commission (SEC), incorporating by...
Alvotech Q4 2025 and Full Year 2025 Financial Results
GlobeNewswire, Inc.
REYKJAVIK, Iceland, March 18, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ US: ALVO, ICELAND: ALVO, STOCKHOLM: ALVO SDB) Financial Highlights A supplemental long‑form earnings release providing additional operational details and business update for...
Oculis Announces Topline Results from DIAMOND Phase 3 Trials with OCS-01 in Diabetic Macular Edema
GlobeNewswire, Inc.
The primary endpoint of mean change in best corrected visual acuity (BCVA) from baseline to week 52 in both Phase 3 trials was not met The secondary endpoint of retinal thickness showed a substantial and persistent reduction with OCS-01 vs vehicle...
Botanical Lemonade Seltzer Market Forecast Report Featuring Segment Analysis And Strategic Industry Insight
EIN Presswire
The Business Research Company's Botanical Lemonade Seltzer Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035 LONDON, GREATER LONDON, UNITED KINGDOM, June 23, 2026 /EINPresswire.com/ -- "The botanical lemonade seltzer market...
Alvotech to Report Fourth Quarter and Full Year 2025 Financial Results
GlobeNewswire, Inc.
REYKJAVIK, Iceland, March 04, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that it...
Green Group World Ocean Day communique
Government of Slovenia
SLOVENIA, June 8 - On World Ocean Day, we recognize and celebrate the ocean—Earth’s most vital life-support system and an irreplaceable resource that deserves immediate and sustained protection.
Oculis to Participate in Upcoming Investor Conferences
GlobeNewswire, Inc.
ZUG, Switzerland, April 07, 2026 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with...
European Commission grants marketing authorization to Pharming’s Joenja® (leniolisib) – the first approved treatment for APDS in the European Union
GlobeNewswire, Inc.
Joenja® (leniolisib) is first approved treatment in the European Union for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a rare primary immunodeficiency, in adult and pediatric patients aged 12 years and older First European...
Costco Wholesale Corporation Reports June Sales Results and Announces Quarterly Cash Dividend
GlobeNewswire, Inc.
ISSAQUAH, Wash., July 08, 2026 (GLOBE NEWSWIRE) -- Costco Wholesale Corporation (“Costco” or the “Company”) (Nasdaq: COST) today reported net sales of $29.24 billion for the retail month of June, the five weeks ended July 5, 2026, an increase of...
VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland
GlobeNewswire, Inc.
— The lowered pricing structure is now available for 16.984 ISK per bottle at pharmacies throughout Iceland AMSTERDAM, March 18, 2026 (GLOBE NEWSWIRE) -- VIVUS BV, a subsidiary of VIVUS LLC, a biopharmaceutical company committed to the development...
Calidi Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Operational Highlights
GlobeNewswire, Inc.
Presented new data on CLD-401 at the AACR conference in San Diego, CA, detailing the profound immune changes in the tumor microenvironment induced by CLD-401; IND filing for CLD-401 expected by end of 2026 Presented new data on RedTail at the AACR...
Oculis Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Optic Neuritis Registrational Trial
GlobeNewswire, Inc.
Special Protocol Assessment (SPA) agreement with the U.S. FDA provides regulatory alignment on the registrational path for Privosegtor in optic neuritis (ON) FDA Breakthrough Therapy and EMA PRIME designations in ON underscore the significant...
Pharming Group reports first quarter 2026 financial results; on track for Joenja® U.S. pediatric label expansion and launches in Japan and Europe in 2026
GlobeNewswire, Inc.
First quarter 2026 total revenues were US$72.4 million, an 8% decrease compared to the first quarter 2025 RUCONEST® revenue was US$58.4 million, a 15% decrease compared to the first quarter 2025, mainly due to anticipated inventory drawdowns and...
waterproof aprons for kids Market Value Expected To Grow At 8.2% CAGR, Reaching $2.48 Billion By 2030
EIN Presswire
The Business Research Company’s waterproof aprons for kids Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 LONDON, GREATER LONDON, UNITED KINGDOM, June 3, 2026 /EINPresswire.com/ -- The market for waterproof aprons...
Pharming Group receives positive CHMP opinion for Joenja® (leniolisib) for the treatment of APDS in adult and pediatric patients 12 years and older
GlobeNewswire, Inc.
If approved, Joenja® (leniolisib) would become the first approved treatment in the European Union for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a rare primary immunodeficiency Decision based on Phase II/III clinical data...
Oculis Publishes Results of 2026 Annual General Meeting and Announces Election of Gregory D. Perry to its Board of Directors
GlobeNewswire, Inc.
ZUG, Switzerland, May 14, 2026 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis” or the “Company”), today announced the results from its 2026 Annual General Meeting held on May 13, 2026 at Ochsen-Zug, Kolinplatz 11, CH-6300...
VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland
GlobeNewswire, Inc.
— The lowered pricing structure is now available for 101.82 EUR per bottle at pharmacies throughout Finland AMSTERDAM, March 18, 2026 (GLOBE NEWSWIRE) -- VIVUS BV, a subsidiary of VIVUS LLC, a biopharmaceutical company committed to the development...
Sign up for:
Iceland Health Focus
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.